Prevention of atrial arrhythmias by pacing;Prävention von vorhofarrhythmien durch stimulation

Herz

Volumn 26, Issue 1, 2001, Pages 18-29

  Funck, Reinhard C ^a   Pomsel, Karsten ^a   Grimm, Wolfram ^a   Hufnagel, Günter ^a   Maisch, Bernhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Antitachycardia pacing; Atrial fibrillation; Atrial flutter; Pacemaker; Prevention; Preventive pacing; Stimulation

Indexed keywords

ANTICOAGULATION; ARTICLE; DISEASE CONTROL; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM CONTRACTION; HEART PACING; HEART VENTRICLE REMODELING; MEDICAL CARE; QUALITY OF LIFE; RECURRENT DISEASE; THROMBOEMBOLISM;

EID: 17144463762     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00002002     Document Type: Article

References (52)

1. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: A randomized controlled trial
2. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: A new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle
3. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome
4. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat
5. Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation
6. Multisite pacing for prevention of atrial tachyarrhythmias: Potential mechanisms
7. Novel preventive pacing algorithms aiming to stop atrial fibrillation from starting
8. Left atrial size and the risk of stroke and death. The Framingham Heart Study
9. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
10. Effects of an acute increase in atrial pressure on atrial refractoriness in humans
11. Effect of the atrioventricular relationship on atrial refractoriness in humans
12. Early results of the AF therapy study: Onset mechanisms
13. Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset
14. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardio-version. A meta-analysis of randomized control trials
15. The atrial arrhythmia syndrome of vagal origin
16. Long-term preven-tion of vagal atrial arrhythmias by atrial pacing at 90/minute: Experience with 6 cases
17. Permanent atrial resynchronization by synchronous bi-atrial pacing in the preventive treatment of atrial flutter associated with high degree interatrial block
18. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pace-makers of 617 patients: The AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance
19. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention
20. Influence of cardiac pacing mode on the long-term development of atrial fibrillation
21. Methoden der kardialen Elektrostimulation zur Prophyiaxe von Vorhofflimmern/Vorhofflattern
22. Atrial overdriving ist beneficial in patients with atrial arrhythmia - The first results of the PROVE study
23. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive
24. Lone atrial fibrillation: Epidemiology and natural history
25. The acute effects of biatrial pacing on atrial depolarization and repolarization
26. Atrial ectopic activity associated with sinus bradycardia
27. Ein neues Stimulationssystem zur Therapie von Vorhoftachyarrhythmien: Der AT500 (Medtronic inc.)
28. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: The hidden benefits of dual-chamber pacing
29. In wieweit stellt ein neuartiges Schrittmachersystem mit atrialen Präventiv- und Über-stimulationsöglichkeiten eine weitere Therapieoption zur Behandiung von paroxysmalem Vorhofflimmern dar? Erste weltweite Ergebnisse der Multicenter AT500
30. Efficacy of automatic atrial antitachcardia pacing for termination of atrial flutter: First clinical results
31. Epidemiologic features of chronic atrial fibrillation: The Framingham study
32. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates
33. Atrial stimulation preference (APP): A new pacing al-gorithm to reduce the incidence of atrial fibrillation
34. Klinischer Stellenwert gegenwärtiger Herzschrittmachertherapie
35. Device management of paroxysmal atrial fibrillation using the dynamic overdrive algorithm
36. Epidemiology and classification of atrial fibrillation
37. Atrial fibrillation: Current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology
38. Dispersion of refractorinessand atrial fibrillation
39. Modes of onset of spontaneous episodes of atrial fibrillation: Implications for the prevention of atrial fibrillation by pacing
40. Recognition, clinical assess-ment and management of arrhythmias and conduction disturbances
41. Interatrial septum pacing: A new approach to prevent recurrent atrial fibrillation
42. Site-dependent intra-atrial conduction delay. Relationship to initiation of atrial fibrillation
43. Spezielle Schrittmacherfunktionen und -systeme zur Prävention von Vorhofflimmern
44. Management of atrial fibrillation: Rate vs rhythm control
45. Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: Observations on the role of trial design and implications of drug-related mortality
46. Longterm follow-up of patients with sick sinus syndrome: A comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups
47. Atrial septal pacing: A method for pacing both atria simultaneously
48. Vorhofgestützte Schrittmachertherapie: Analyse intraatrialer Leitungszeiten zur Optimierung der Elektrodenpositionierung
49. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome
50. Influence of blood pressure on left atrial size. The Framingham Heart Study
51. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
52. Impact of atrial fibrillation on mortality, stroke, and medical costs